Overcoming Fixed Sample Challenges to Unlock Integrated Multiomics Analyses
![Omics-Tech-Spotlight_Webinar2_Laptop Omics-Tech-Spotlight_Webinar2_Laptop](https://web.genewiz.com/hs-fs/hubfs/05-2023%20Genomics%20Innovation%20Spotlight/2024-02%20GEN%20-%20Technology%20Spotlight%20Webinar%20Series/Webinar%202%20-%20FFPE-Multiomics/Landing%20Page/Omics-Tech-Spotlight_Webinar2_Laptop.png?width=400&height=242&name=Omics-Tech-Spotlight_Webinar2_Laptop.png)
About the workshop
Working with Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples can be challenging. However, recent technological advances now make it possible to accommodate this unique sample type. In this webinar, discover how to leverage these improvements in an integrated multiomics workflow, including genomics, epigenomics, transcriptomics, and proteomics, and review example analyses with sample data across several tumor types.
What you'll learn about
- The latest technological advancements in FFPE sample processing
- How and when to integrate genomics, epigenomics, single cell, and spatial profiling in your research
- How to build a comprehensive and end-to-end multiomics workflow for maximal insights
Unable to attend live? Register today and we’ll send the recording to watch at your convenience.
About the presenter
![10014-D_Omics-Tech-Spotlight_AndreaOHara](https://web.genewiz.com/hubfs/05-2023%20Genomics%20Innovation%20Spotlight/2024-02%20GEN%20-%20Technology%20Spotlight%20Webinar%20Series/Webinar%202%20-%20FFPE-Multiomics/Landing%20Page/10014-D_Omics-Tech-Spotlight_AndreaOHara.png)
Andrea O'Hara, Ph.D.
Senior Product Manager, Azenta Life Sciences
With over a decade of experience with multiomics technologies, Dr. Andrea O’Hara guides technological innovations and life-cycle management at Azenta. She earned her Ph.D. from the University of North Carolina at Chapel Hill in genetics and molecular biology and a B.A. in biology from The John Hopkins University. Dr. O’Hara completed her postdoctoral training at the National Institutes of Health, focusing on genomic alterations in various endometrial cancers.